VAERS Explorer
Back to explore

Report #2854780

Received Aug 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
GA
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK013A21AIM

Symptoms (2)

Lichen planusLichen sclerosus

Symptom narrative

lichen planus; lichen sclerosis; This spontaneous case was reported by a consumer and describes the occurrence of LICHEN PLANUS (lichen planus) and LICHEN SCLEROSUS (lichen sclerosis) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced LICHEN PLANUS (lichen planus) and LICHEN SCLEROSUS (lichen sclerosis). At the time of the report, LICHEN PLANUS (lichen planus) and LICHEN SCLEROSUS (lichen sclerosis) had resolved with sequelae. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Reporter causality was not reported.